ARTICLE | Clinical News
Ceplene histamine dihydrochloride regulatory update
October 29, 2001 8:00 AM UTC
MAXM received three U.S. patents and notice of allowance for a U.S. patent covering Ceplene to treat cancer and hepatitis. No. 6,221,893, covers the administration of histamine and related compounds f...